Cardiomyocyte Specific Deletion of Crif1 Causes Mitochondrial Cardiomyopathy in Mice

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Shin, Juhee ^a,b   Lee, Seok Hong ^c   Kwon, Min Chul ^a   Yang, Dong Kwon ^d   Seo, Ha Rim ^a   Kim, Jaetaek ^c   Kim, Yoon Young ^a,b   Im, Sun Kyoung ^a,b   Abel, Evan Dale ^e   Kim, Kyong Tai ^b   Park, Woo Jin ^d   Kong, Young Yun ^a  

^a Seoul National University   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Chung Ang University   (South Korea)

^d Gwangju Institute of Science and Technology (GIST)   (South Korea)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CRIF1 PROTEIN; MITOCHONDRIAL DNA; NUCLEAR PROTEIN; PROSTAGLANDIN SYNTHASE; SUCCINATE DEHYDROGENASE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL RESPIRATION; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; GENE DELETION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HISTOPATHOLOGY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL MYOPATHY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PROTEIN FUNCTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIOMYOPATHIES; CELL CYCLE PROTEINS; CELL RESPIRATION; CROSSES, GENETIC; GENE DELETION; HEART FAILURE; INTEGRASES; MICE; MICE, TRANSGENIC; MITOCHONDRIA, HEART; MYOCARDIUM; MYOCYTES, CARDIAC; OXYGEN CONSUMPTION; TAMOXIFEN;

MUS; MUS MUSCULUS;

EID: 84871915529     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053577     Document Type: Article

References (41)

1. Schmidt O, Pfanner N, Meisinger C, (2010) Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol 11: 655-667.
2. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, et al. (2008) A mitochondrial protein compendium elucidates complex I disease biology. Cell 134: 112-123.
3. Calvo SE, Mootha VK, (2010) The mitochondrial proteome and human disease. Annu Rev Genomics Hum Genet 11: 25-44.
4. Ryan MT, Hoogenraad NJ, (2007) Mitochondrial-nuclear communications. Annu Rev Biochem 76: 701-722.
5. Kwon MC, Koo BK, Kim YY, Lee SH, Kim NS, et al. (2009) Essential role of CR6-interacting factor 1 (Crif1) in E74-like factor 3 (ELF3)-mediated intestinal development. J Biol Chem 284: 33634-33641.
6. Kwon MC, Koo BK, Moon JS, Kim YY, Park KC, et al. (2008) Crif1 is a novel transcriptional coactivator of STAT3. EMBO J 27: 642-653.
7. Chung HK, Yi YW, Jung NC, Kim D, Suh JM, et al. (2003) CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle. J Biol Chem 278: 28079-28088.
8. Park KC, Song KH, Chung HK, Kim H, Kim DW, et al. (2005) CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation. Mol Endocrinol 19: 12-24.
9. Suh JH, Shong M, Choi HS, Lee K, (2008) CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction. Mol Endocrinol 22: 33-46.
10. Kim SJ, Kwon MC, Ryu MJ, Chung HK, Tadi S, et al. (2012) CRIF1 Is Essential for the Synthesis and Insertion of Oxidative Phosphorylation Polypeptides in the Mammalian Mitochondrial Membrane. Cell Metab 16: 274-283.
11. Skladal D, Halliday J, Thorburn DR, (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126: 1905-1912.
12. Pfeffer G, Chinnery PF (2011) Diagnosis and treatment of mitochondrial myopathies. Ann Med.
13. Wallace DC, Fan W, Procaccio V, (2010) Mitochondrial energetics and therapeutics. Annu Rev Pathol 5: 297-348.
14. Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, et al. (2007) Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 120: 1326-1333.
15. Kirby DM, Thorburn DR, (2008) Approaches to finding the molecular basis of mitochondrial oxidative phosphorylation disorders. Twin Res Hum Genet 11: 395-411.
16. Antozzi C, Zeviani M, (1997) Cardiomyopathies in disorders of oxidative metabolism. Cardiovasc Res 35: 184-199.
17. Marin-Garcia J, Goldenthal MJ, (1997) Mitochondrial cardiomyopathy: molecular and biochemical analysis. Pediatr Cardiol 18: 251-260.
18. Lev D, Nissenkorn A, Leshinsky-Silver E, Sadeh M, Zeharia A, et al. (2004) Clinical presentations of mitochondrial cardiomyopathies. Pediatr Cardiol 25: 443-450.
19. Holmgren D, Wahlander H, Eriksson BO, Oldfors A, Holme E, et al. (2003) Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J 24: 280-288.
20. Scaglia F, Towbin JA, Craigen WJ, Belmont JW, Smith EO, et al. (2004) Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics 114: 925-931.
21. Wallace DC, Fan W, (2009) The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev 23: 1714-1736.
22. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, et al. (2001) Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 89: 20-25.
23. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, et al. (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2: 559-569.
24. Sciacco M, Bonilla E, (1996) Cytochemistry and immunocytochemistry of mitochondria in tissue sections. Methods Enzymol 264: 509-521.
25. Lee SH, Yang DK, Choi BY, Lee YH, Kim SY, et al. (2009) The transcription factor Eya2 prevents pressure overload-induced adverse cardiac remodeling. J Mol Cell Cardiol 46: 596-605.
26. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, Saks VA, (1987) Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta 892: 191-196.
27. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, et al. (2005) Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112: 2686-2695.
28. Li CH, Tzeng SL, Cheng YW, Kang JJ, (2005) Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway. J Biol Chem 280: 26193-26199.
29. Barrientos A, Barros MH, Valnot I, Rotig A, Rustin P, et al. (2002) Cytochrome oxidase in health and disease. Gene 286: 53-63.
30. Brandt U, (2006) Energy converting NADH:quinone oxidoreductase (complex I). Annu Rev Biochem 75: 69-92.
31. Cramer WA, Zhang H, Yan J, Kurisu G, Smith JL, (2006) Transmembrane traffic in the cytochrome b6f complex. Annu Rev Biochem 75: 769-790.
32. Janssen RJ, Nijtmans LG, van den Heuvel LP, Smeitink JA, (2006) Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis 29: 499-515.
33. Cecchini G, (2003) Function and structure of complex II of the respiratory chain. Annu Rev Biochem 72: 77-109.
34. Adoutte A, Balmefrezol M, Beisson J, Andre J, (1972) The effects of erythromycin and chloramphenicol on the ultrastructure of mitochondria in sensitive and resistant strains of Paramecium. J Cell Biol 54: 8-19.
35. Sumegi B, Freeman DA, Inman L, Srere PA, (1988) Studies on a possible molecular basis for the structure of mitochondrial cristae. J Mol Recognit 1: 19-24.
36. Lenk R, Penman S, (1971) Morphological studies of cells grown in the absence of mitochondrial-specific protein synthesis. J Cell Biol 49: 541-546.
37. Lipton JH, McMurray WC, (1977) Mitochondrial biogenesis in cultured animal cells. I. Effect of chloramphenicol on morphology and mitochondrial respiratory enzymes. Biochim Biophys Acta 477: 264-272.
38. Clark-Walker GD, Linnane AW, (1967) The biogenesis of mitochondria in Saccharomyces cerevisiae. A comparison between cytoplasmic respiratory-deficient mutant yeast and chlormaphenicol-inhibited wild type cells. J Cell Biol 34: 1-14.
39. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H, (2007) Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev 12: 331-343.
40. Stanley WC, Recchia FA, Lopaschuk GD, (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85: 1093-1129.
41. Smith R, (2007) Parturition. N Engl J Med 356: 271-283.